Inventor · disambiguated record
Darren Harvey
Also filed as: HARVEY DARREN · HARVEY DARREN M · HARVEY DARREN MARTIN
15 granted patents·20 pending applications·663 citations·filing 2004–2023
91Inventor score
Top patents by PatentIndex Score
35 records- 0196US7799782B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 21, 2010·600 cites·23 claims
- 0288US9663524B2Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitorsCELGENE CAR LLC·Filed 2014·Granted May 30, 2017·15 cites·27 claims
- 0385US7521447B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Apr 21, 2009·28 cites·33 claims
- 0483US8044083B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 0581US10266526B2Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancerEPIZYME INC·Filed 2015·Granted Apr 23, 2019·3 cites·17 claims
- 0679US8039639B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Granted Oct 18, 2011·4 cites·1 claims
- 0777US10065966B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2017·Granted Sep 4, 2018·2 cites·27 claims
- 0876US12116358B2Substituted indoles and methods of use thereofEPIZYME INC·Filed 2019·Granted Oct 15, 2024·1 cites·70 claims
- 0974US2023101819A1SMYD InhibitorsEPIZYME INC·Filed 2021·Application pending·0 cites
- 1073US8017641B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 13, 2011·1 cites·10 claims
- 1172US2023357208A1Myst family histone acetyltransferase inhibitorsEPIZYME INC·Filed 2023·Application pending·0 cites
- 1271US8518983B2P38 inhibitors and methods of use thereofMUNSON MARK·Filed 2009·Granted Aug 27, 2013·2 cites·8 claims
- 1367US2021198252A1Smyd inhibitorsEPIZYME INC·Filed 2020·Application pending·0 cites
- 1466US8809538B2Piperidine-containing compounds and use thereofRODRIGUEZ MARTHA E·Filed 2010·Granted Aug 19, 2014·2 cites·6 claims
- 1562US10618902B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2018·Granted Apr 14, 2020·0 cites·15 claims
- 1661US2020102314A1Substituted pyrrolidine compoundsEPIZYME INC·Filed 2019·Application pending·0 cites
- 1761US2021198277A1Amine-substituted aryl or heteroaryl compoundsEPIZYME INC·Filed 2020·Application pending·0 cites
- 1861US2023046656A1Crebbp related cancer therapyEPIZYME INC·Filed 2022·Application pending·0 cites
- 1961US2019322660A1Smyd inhibitorsEPIZYME INC·Filed 2019·Application pending·0 cites
- 2060US11685732B2MYST family histone acetyltransferase inhibitorsEPIZYME INC·Filed 2018·Granted Jun 27, 2023·0 cites·8 claims
- 2160US2020048195A1Substituted pyrrolidine carboxamide compoundsEPIZYME INC·Filed 2019·Application pending·0 cites
- 2254US2024376100A1Papd5 and/or papd7 inhibiting 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid derivativesREDONA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2353US2020148650A1Isoxazole carboxamide compoundsEPIZYME INC·Filed 2019·Application pending·0 cites
- 2450US2017253601A1Substituted Pyrrolidine CompoundsEPIZYME INC·Filed 2015·Application pending·0 cites
- 2550US2017247326A1Substituted Pyrrolidine Carboxamide CompoundsEPIZYME INC·Filed 2015·Application pending·0 cites
- 2648US2022144812A1Quinoline derivatives and their use for the treatment of cancerEPIZYME INC·Filed 2020·Application pending·0 cites
- 2748US2024254136A1Compounds targeting rna-binding proteins or rna-modifying proteinsREDONA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2847US2017355712A1Amine-substituted aryl or heteroaryl compoundsEPIZYME INC·Filed 2017·Application pending·0 cites
- 2946US2022356174A1Pyridin-2-one compounds useful as smarca2 antagonistsEPIZYME INC·Filed 2019·Application pending·0 cites
- 3044US10428029B2Isoxazole carboxamide compoundsEPIZYME INC·Filed 2015·Granted Oct 1, 2019·0 cites·10 claims
- 3141US2014228349A15,7-substituted-imidazo[1,2-c]pyrimidinesARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3240US2019270797A1Crebbp related cancer therapyEPIZYME INC·Filed 2017·Application pending·0 cites
- 3340US2009227555A2Novel Pyridine CompoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3439US2022267260A1Compounds containing a sulfonic group as kat inhibitorsEPIZYME INC·Filed 2017·Application pending·0 cites
- 3534US8962596B25,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinasesBURGESS LAURENCE E·Filed 2011·Granted Feb 24, 2015·0 cites·38 claims
Join the waitlist — get patent alerts
Get an alert when Darren Harvey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →